Apelin Deficiency Accelerates the Progression of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the selective loss of motor neurons. Recent studies have implicated that chronic hypoxia and insufficient vascular endothelial growth factor (VEGF)-dependent neuroprotection may lead to the degeneration of motor neurons in ALS. Expression of apelin, an endogenous ligand for the G protein-coupled receptor APJ, is regulated by hypoxia. In addition, recent reports suggest that apelin protects neurons against glutamate-induced excitotoxicity. Here, we examined whether apelin is an endogenous neuroprotective factor using SOD1G93A mouse model of ALS. In mouse CNS tissues, the highest expressions of both apelin and APJ mRNAs were detected in spinal cord. APJ immunoreactivity was observed in neuronal cell bodies located in gray matter of spinal cord. Although apelin mRNA expression in the spinal cord of wild-type mice was not changed from 4 to 18 weeks age, that of SOD1G93A mice was reduced along with the paralytic phenotype. In addition, double mutant apelin-deficient and SOD1G93A displayed the disease phenotypes earlier than SOD1G93A littermates. Immunohistochemical observation revealed that the number of motor neurons was decreased and microglia were activated in the spinal cord of the double mutant mice, indicating that apelin deficiency pathologically accelerated the progression of ALS. Furthermore, we showed that apelin enhanced the protective effect of VEGF on H2O2-induced neuronal death in primary neurons. These results suggest that apelin/APJ system in the spinal cord has a neuroprotective effect against the pathogenesis of ALS.

[1]  M. Dichter,et al.  Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury , 2007, Journal of neurochemistry.

[2]  H. Ischiropoulos,et al.  Oxidative stress and nitration in neurodegeneration: cause, effect, or association? , 2003, The Journal of clinical investigation.

[3]  C. Howe,et al.  SUBCUTANEOUS IGF-1 IS NOT BENEFICIAL IN 2-YEAR ALS TRIAL , 2009, Neurology.

[4]  H. Lahlou,et al.  Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein. , 2002, Biochemical and biophysical research communications.

[5]  H. Heng,et al.  A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. , 1993, Gene.

[6]  L. Viera,et al.  Mutant Cu/Zn-Superoxide Dismutase Associated with Amyotrophic Lateral Sclerosis Destabilizes Vascular Endothelial Growth Factor mRNA and Downregulates Its Expression , 2007, The Journal of Neuroscience.

[7]  P. Krieg,et al.  Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. , 2006, Developmental biology.

[8]  M. Cornu,et al.  Apelin (65‐77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  K. Jin,et al.  Vascular Endothelial Growth Factor Overexpression Delays Neurodegeneration and Prolongs Survival in Amyotrophic Lateral Sclerosis Mice , 2007, The Journal of Neuroscience.

[10]  E. Haller,et al.  Evidence of Compromised Blood-Spinal Cord Barrier in Early and Late Symptomatic SOD1 Mice Modeling ALS , 2007, PloS one.

[11]  Y. Yoshioka,et al.  Nitric oxide inhibits lipopolysaccharide-induced inducible nitric oxide synthase expression and its own production through the cGMP signaling pathway in murine microglia BV-2 cells. , 2010, Journal of pharmacological sciences.

[12]  Ling Wei,et al.  Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons. , 2010, Experimental cell research.

[13]  M. Gurney,et al.  Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS , 1998 .

[14]  R. Deane,et al.  ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration , 2008, Nature Neuroscience.

[15]  M. Dichter,et al.  Human Immunodeficiency Virus (HIV)-Induced Neurotoxicity: Roles for the NMDA Receptor Subtypes , 2006, The Journal of Neuroscience.

[16]  Gabriele Siciliano,et al.  Lithium delays progression of amyotrophic lateral sclerosis , 2008, Proceedings of the National Academy of Sciences.

[17]  Jeffrey D. Rothstein,et al.  From charcot to lou gehrig: deciphering selective motor neuron death in als , 2001, Nature Reviews Neuroscience.

[18]  A. Levey,et al.  Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis , 1995, Annals of neurology.

[19]  S. Mckercher,et al.  Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis , 2006, Proceedings of the National Academy of Sciences.

[20]  J. Iłżecka.  Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis , 2004, Clinical Neurology and Neurosurgery.

[21]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[22]  Robert P. Davis,et al.  Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin , 2003, Journal of neurochemistry.

[23]  Till Acker,et al.  Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration , 2001, Nature Genetics.

[24]  N. Mochizuki,et al.  Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis , 2008, The EMBO journal.

[25]  G. Kollias,et al.  Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia , 2006, Science.

[26]  H. Mitsumoto,et al.  Genetic Transfer of the Wobbler Gene to a C57BL/6J × NZB Hybrid Stock: Natural History of the Motor Neuron Disease and Response to CNTF and BDNF Cotreatment , 1997, Experimental Neurology.

[27]  Y. Tano,et al.  Retardation of Retinal Vascular Development in Apelin-Deficient Mice , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[28]  P. Tsao,et al.  Apelin is necessary for the maintenance of insulin sensitivity. , 2009, American journal of physiology. Endocrinology and metabolism.

[29]  M. Gurney,et al.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.

[30]  J. Julien,et al.  Wild‐type superoxide dismutase acquires binding and toxic properties of ALS‐linked mutant forms through oxidation , 2007, Journal of neurochemistry.

[31]  Y. Yoshioka,et al.  Apelin Is a Crucial Factor for Hypoxia-Induced Retinal Angiogenesis , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[32]  S. Hinuma,et al.  Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. , 1998, Biochemical and biophysical research communications.

[33]  F. Gage,et al.  Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model , 2003, Science.

[34]  I. Ay,et al.  IGF-1:Tetanus toxin fragment C fusion protein improves delivery of IGF-1 to spinal cord but fails to prolong survival of ALS mice , 2009, Brain Research.

[35]  I. Castan-Laurell,et al.  Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.